BAIBYS raised $4.5M in a Series A led by Firstime Ventures to develop an AI-based system that selects ideal sperm for fertility treatments.
Amount Raised
$4.5 Million
Round Type
Series A
Tel AvivBiotechnologyHealth CareInvestors
Description
Israeli startup BAIBYS has completed its $4.5 million Series A funding round, which aims to enhance fertility treatment success rates through an autonomous sperm selection system. The round was led by Firstime Ventures, with participation from ROHTO, a Japanese pharmaceutical giant.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as BAIBYS that raised within 45 days of this round, from Fundz verified event records.
- Aktis Oncology raised $175M on September 20, 2024.
- Redcliffe Labs raised $42M (Series C) on September 20, 2024.
- Sparrow BioAcoustics raised $13M (Seed) on September 20, 2024.
- DeepLook Medical raised an undisclosed amount (Series A) on September 19, 2024.
- Cercle raised $6M (Seed) on September 19, 2024.
- Alesi Surgical raised $6.6M (Funding Round) on September 19, 2024.
Who to call at BAIBYS, and when
A new round usually means BAIBYS is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BAIBYS raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BAIBYS, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BAIBYS. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BAIBYS raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBAIBYS raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.